Qualigen Therapeutics
QLGN
QLGN
26 hedge funds and large institutions have $3.61M invested in Qualigen Therapeutics in 2021 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
28% less capital invested
Capital invested by funds: $5.05M → $3.61M (-$1.43M)
Holders
26
Holding in Top 10
–
Calls
$73K
Puts
$21K
Top Buyers
| 1 | +$198K | |
| 2 | +$130K | |
| 3 | +$107K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$102K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$68.2K |
Top Sellers
| 1 | -$227K | |
| 2 | -$90K | |
| 3 | -$27K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$23.5K |
| 5 |
HC
Hatton Consulting
Phoenix,
Arizona
|
-$13K |